WHO ICTRP trial
Blood sampling of oncology patients treated with monoclonal antibodies
NL-OMON27631 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON27631 |
|---|---|
| Public title | Blood sampling of oncology patients treated with monoclonal antibodies |
| Scientific title | Prospective sampling in intravenously treated oncology patients: monoclonal antibodies |
| Primary sponsor | Erasmus Medical Center |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Observational non invasive |
| Conditions | All malignancies that are treated with intravenous monoclonal antibodies |
| Registration date | Feb 6, 2018 |
| Target size | 1000 |
| Secondary IDs | NL6828;NTR7015; : MEC 16-011 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: